Diabetes and risk of community-acquired respiratory tract infections, urinary tract infections, and bacteremia

Open Infectious Diseases Journal

Volumn 6, Issue SPEC ISS 1, 2012, Pages 27-39

  Thomsen, Reimar W ^a   Mor, Anil ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Bacteremia; Diabetes; Epidemiology; Hyperglycemia; Infection; Pneumonia; Risk; Sepsis; Urinary tract infection

Indexed keywords

ANTIBIOTIC AGENT; INFLUENZA VACCINE; INSULIN; ORAL ANTIDIABETIC AGENT; PNEUMOCOCCUS VACCINE;

ASYMPTOMATIC BACTERIURIA; BACTEREMIA; CYSTITIS; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE DURATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENTEROBACTERIACEAE INFECTION; GLYCEMIC CONTROL; GROUP B STREPTOCOCCAL INFECTION; HEMOLYTIC STREPTOCOCCUS; HUMAN; HYPERGLYCEMIA; IMMUNE RESPONSE; INFECTION RISK; INFLAMMATION; INFLUENZA; LUNG TUBERCULOSIS; METABOLIC DISORDER; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PNEUMOCOCCAL INFECTION; PNEUMONIA; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PYELONEPHRITIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY TRACT INFECTION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEPSIS; STAPHYLOCOCCAL BACTEREMIA; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; URINARY TRACT INFECTION;

EID: 84875417540     PISSN: None     EISSN: 18742793     Source Type: Journal    
DOI: 10.2174/1874279301206010027     Document Type: Review

References (188)

1. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001; 414(6865): 782-7.
2. Carstensen B, Kristensen JK, Ottosen P, Borch-Johnsen K. The Danish National Diabetes Register: trends in incidence, prevalence and mortality. Diabetologia 2008; 51(12): 2187-96.
3. Danaei G, Finucane MM, Lu Y, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2-À7 million participants. Lancet 2011; 378(9785): 31-40.
4. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010; 87(1): 4-14.
5. Almdal T, Scharling H, Jensen JS, Vestergaard H. The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up. Arch Intern Med 2004; 164(13): 1422-6.
6. Nolan CJ, Damm P, Prentki M. Type 2 diabetes across generations: from pathophysiology to prevention and management. Lancet 2009; 378(9786): 169-81.
7. Roglic G, Unwin N. Mortality attributable to diabetes: estimates for the year 2010. Diabetes Res Clin Pract 2010; 87(1): 15-9.
8. McEwen LN, Kim C, Karter AJ, et al. Risk factors for mortality among patients with diabetes: the Translating Research Into Action for Diabetes (TRIAD) Study. Diabetes Care 2007; 30(7): 1736-41.
9. Larkin JG, Frier BM, Ireland JT. Diabetes mellitus and infection. Postgrad Med J 1985; 61(713): 233-7.
10. Boyko EJ, Lipsky BA: Infection and diabetes mellitus. In: Harris MI, Ed. Diabetes in America. 2nd ed. Washington, DC: National Institutes of Health 1995; pp. 485-96.
11. Tan JS. Infectious complications in patients with diabetes mellitus. Int Diabetes Monit 2000; 12(2): 1-7.
12. Joshi N, Caputo GM, Weitekamp MR, Karchmer AW. Infections in patients with diabetes mellitus. N Engl J Med 1999; 341(25): 1906-12.
13. Jackson LA. Evaluating diabetes mellitus as a risk factor for community-acquired infections. Clin Infect Dis 2005; 41(3): 289-90.
14. Peleg AY, Weerarathna T, McCarthy JS, Davis TME. Common infections in diabetes: pathogenesis, management and relationship to glycemic control. Diabetes Metab Res Rev 2007; 23(1): 3-13.
15. Stegenga ME, van der Crabben SN, Blumer RME, et al. Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia. Blood 2008; 112(1): 82-9.
16. Foss-Freitas MC, Foss NT, Donadi EA, Foss MC. Effect of the glycemic control on intracellular cytokine production from peripheral blood mononuclear cells of type 1 and type 2 diabetic patients. Diabetes Res Clin Pract 2008; 82(3): 329-34.
17. Pontin AR, Barnes RD, Joffe J, Kahn D. Emphysematous pyelonephritis in diabetic patients. Br J Urol 1995; 75(1): 71-4.
18. Gill GV, Famuyiwa OO, Rolfe M, Archibald LK. Tropical diabetic hand syndrome. Lancet 1998; 351(9096): 113-4.
19. Koh GC, Peacock SJ, van der Poll T, Wiersinga WJ. The impact of diabetes on the pathogenesis of sepsis. Eur J Clin Microbiol Infect Dis 2012; 31(4): 379-88.
20. Heron M, Hoyert DL, Murphy SL, Xu J, Kochanek KD, Tejada-Vera B. Deaths: final data for 2006. Natl Vital Stat Rep 2009; 57(14): 1-134.
21. Fry AM, Shay DK, Holman RC, Curns AT, Anderson LJ. Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988-2002. JAMA 2005; 294(21): 2712-9.
22. Thomsen RW, Riis A, Norgaard M, et al. Rising incidence and persistently high mortality of hospitalized pneumonia: a 10-year population-based study in Denmark. J Intern Med 2006; 259(4): 410-7.
23. Trotter CL, Stuart JM, George R, Miller E. Increasing hospital admissions for pneumonia, England. Emerging Infect Dis 2008; 14(5): 727-33.
24. Gageldonk-Lafeber AB, Bogaerts MA, Verheij RA, van der Sande MA. Time trends in primary-care morbidity, hospitalization and mortality due to pneumonia. Epidemiol Infect 2009; 137(10): 1472-8.
25. Koziel H, Koziel MJ. Pulmonary complications of diabetes mellitus. Pneumonia. Infect Dis Clin North Am 1995; 9(1): 65-96.
26. Kornum JB, Thomsen RW, Riis A, Lervang HH, Schonheyder HC, Sorensen HT. Diabetes, glycemic control, and risk of hospitalization with pneumonia: a population-based case-control study. Diabetes Care 2008; 31(8): 1541-5.
27. American Diabetes Association. Standards of medical care in diabetes--2011. Diabetes Care 2011; 34 (Suppl 1): S11-61.
28. Smith SA, Poland GA. Use of influenza and pneumococcal vaccines in people with diabetes. Diabetes Care 2000; 23(1): 95-108.
29. Shah BR, Hux JE. Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care 2003; 26(2): 510-3.
30. Jackson ML, Neuzil KM, Thompson WW, et al. The burden of community-acquired pneumonia in seniors: results of a populationbased study. Clin Infect Dis 2004; 39(11): 1642-50.
31. O'Meara ES, White M, Siscovick DS, Lyles MF, Kuller LH. Hospitalization for pneumonia in the Cardiovascular Health Study: incidence, mortality, and influence on longer-term survival. J Am Geriatr Soc 2005; 53(7): 1108-16.
32. Muller LM, Gorter KJ, Hak E, et al. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis 2005; 41(3): 281-8.
33. Benfield T, Jensen JS, Nordestgaard BG. Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome. Diabetologia 2007; 50(3): 549-54.
34. Lipsky BA, Boyko EJ, Inui TS, Koepsell TD. Risk factors for acquiring pneumococcal infections. Arch Intern Med 1986; 146(11): 2179-85.
35. Koivula I, Sten M, Makela PH. Risk factors for pneumonia in the elderly. Am J Med 1994; 96(4): 313-20.
36. Lange P, Vestbo J, Nyboe J. Risk factors for death and hospitalization from pneumonia. A prospective study of a general population. Eur Respir J 1995; 8(10): 1694-8.
37. Seshasai SR, Kaptoge S, Thompson A, et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 2011; 364(9): 829-41.
38. Falguera M, Pifarre R, Martin A, Sheikh A, Moreno A. Etiology and outcome of community-acquired pneumonia in patients with diabetes mellitus. Chest 2005; 128(5): 3233-9.
39. Yende S, van der PT, Lee M, et al. The influence of pre-existing diabetes mellitus on the host immune response and outcome of pneumonia: analysis of two multicentre cohort studies. Thorax 2010; 65(10): 870-7.
40. Kornum JB, Thomsen RW, Riis A, Lervang HH, Schonheyder HC, Sorensen HT. Type 2 diabetes and pneumonia outcomes: a population-based cohort study. Diabetes Care 2007; 30(9): 2251-7.
41. McAlister FA, Majumdar SR, Blitz S, Rowe BH, Romney J, Marrie TJ. The relation between hyperglycemia and outcomes in 2,471 patients admitted to the hospital with community-acquired pneumonia. Diabetes Care 2005; 28(4): 810-5.
42. Vaillant L, La Ruche G, Tarantola A, Barboza P. Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009. Eur Surveill 2009; 14(33): pii19309.
43. Centers of Disease Control and Prevention. Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) -United States, May-August 2009. MMWR Morb Mortal Wkly Rep 2009; 58(38): 1071-4.
44. Chandra RK. Immune response in overnutrition. Cancer Res 1981; 41(9 Pt 2): 3795-6.
45. Falagas ME, Kompoti M. Obesity and infection. Lancet Infect Dis 2006; 6(7): 438-46.
46. Kopelman PG. Obesity as a medical problem. Nature 2000; 404(6778): 635-43.
47. Blumentals WA, Nevitt A, Peng MM, Toovey S. Body mass index and the incidence of influenza-associated pneumonia in a UK primary care cohort. Influenza Other Respi Viruses 2012; 6(1): 28-36.
48. Kornum JB, Norgaard M, Dethlefsen C, et al. Obesity and risk of subsequent hospitalisation with pneumonia. Eur Respir J 2010; 36(6): 1330-6.
49. Fiore AE, Uyeki TM, Broder K, et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 2010; 59(RR-8): 1-62.
50. Nam JS, Kim AR, Yoon JC, et al. The humoral immune response to the inactivated influenza A (H1N1) 2009 monovalent vaccine in patients with Type 2 diabetes mellitus in Korea. Diabet Med 2011; 28(7): 815-7.
51. Looijmans-van den Akker I, Verheij TJ, Buskens E, Nichol KL, Rutten GE, Hak E. Clinical effectiveness of first and repeat influenza vaccination in adult and elderly diabetic patients. Diabetes Care 2006; 29(8): 1771-6.
52. Jackson LA, Jackson ML, Nelson JC, Neuzil KM, Weiss NS. Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol 2006; 35(2): 337-44.
53. Jefferson T, Di Pietrantonj C, Rivetti A, Bawazeer GA, Al Ansary LA, Ferroni E. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev 2010; (7): CD001269.
54. Jefferson T, Di Pietrantonj C, Al Ansary LA, Ferroni E, Thorning S, Thomas RE. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev 2010; (2): CD004876.
55. Moberley SA, Holden J, Tatham DP, Andrews RM. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev 2008; (1): CD000422.
56. Flynn JM. The changing cause of death in diabetes mellitus. Am J Med Sci 1935; 189: 157.
57. Restrepo BI. Convergence of the tuberculosis and diabetes epidemics: renewal of old acquaintances. Clin Infect Dis 2007; 45(4): 436-8.
58. Joslin EP. The treatment of diabetes mellitus with observations based upon thirteen hundred cases. 2nd ed. Philadelphia: Lea and Febiger 1917.
59. Jacobsen ATB. Varige resultater af insulinbehandlingen. Hospitalstidende 1928; 33: 20-8.
60. Stevenson CR, Critchley JA, Forouhi NG, et al. Diabetes and the risk of tuberculosis: a neglected threat to public health? Chronic Illn 2007; 3(3): 228-45.
61. Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med 2008; 5(7): e152.
62. Pablos-Mendez A, Blustein J, Knirsch CA. The role of diabetes mellitus in the higher prevalence of tuberculosis among Hispanics. Am J Public Health 1997; 87(4): 574-9.
63. Leung CC, Lam TH, Chan WM, et al. Diabetic control and risk of tuberculosis: a cohort study. Am J Epidemiol 2008; 167(12): 1486-94.
64. Dobler CC, Flack JR, Marks GB. Risk of tuberculosis among people with diabetes mellitus: an Australian nationwide cohort study. BMJ Open 2012; 13(2): e000666.
65. Leegaard A, Riis A, Kornum JB, et al. Diabetes, Glycemic Control, and Risk of Tuberculosis A population-based case-control study. Diabetes Care 2011; 34(12): 2530-5.
66. Dooley KE, Chaisson RE. Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis 2009; 9(12): 737-46.
67. Faurholt-Jepsen D, Range N, Praygod G, et al. Diabetes is a risk factor for pulmonary tuberculosis: a case-control study from Mwanza, Tanzania. PLoS ONE 2011; 6(8): e24215
68. Goldhaber-Fiebert JD, Jeon CY, Cohen T, Murray MB. Diabetes mellitus and tuberculosis in countries with high tuberculosis burdens: individual risks and social determinants. Int J Epidemiol 2011; 40(2): 417-28.
69. Bashar M, Alcabes P, Rom WN, Condos R. Increased incidence of multidrug-resistant tuberculosis in diabetic patients on the Bellevue Chest Service, 1987 to 1997. Chest 2001; 120(5): 1514-9.
70. Fisher-Hoch SP, Whitney E, McCormick JB, et al. Type 2 diabetes and multidrug-resistant tuberculosis. Scand J Infect Dis 2008; 40(11-12): 888-93.
71. Bischoff A, Ekoe T, Perone N, Slama S, Loutan L. Chronic disease management in Sub-Saharan Africa: whose business is it? Int J Environ Res Public Health 2009; 6(8): 2258-70.
72. Beran D, Yudkin JS, de Court M. Access to care for patients with insulin-requiring diabetes in developing countries: case studies of Mozambique and Zambia. Diabetes Care 2005; 28(9): 2136-40.
73. Boutayeb A. The double burden of communicable and noncommunicable diseases in developing countries. Trans R Soc Trop Med Hyg 2006; 100(3): 191-9.
74. Gill GV, Mbanya JC, Ramaiya KL, Tesfaye S. A sub-Saharan African perspective of diabetes. Diabetologia 2009; 52(1): 8-16.
75. Levitt NS. Diabetes in Africa: epidemiology, management and healthcare challenges. Heart 2008; 94(11): 1376-82.
76. Young F, Critchley JA, Johnstone LK, Unwin NC. A review of comorbidity between infectious and chronic disease in Sub Saharan Africa: TB and diabetes mellitus, HIV and metabolic syndrome, and the impact of globalization. Global Health 2009; 5: 9.
77. Foxman B, Barlow R, D'Arcy H, Gillespie B, Sobel JD. Urinary tract infection: self-reported incidence and associated costs. Ann Epidemiol 2000; 10(8): 509-15.
78. Ronald AR, Nicolle LE, Stamm E, et al. Urinary tract infection in adults: research priorities and strategies. Int J Antimicrob Agents 2001; 17(4): 343-8.
79. Stapleton A. Urinary tract infections in patients with diabetes. Am J Med 2002; 113 Suppl 1A: 80S-4.
80. Funfstuck R, Nicolle LE, Hanefeld M, Naber KG. Urinary tract infection in patients with diabetes mellitus. Clin Nephrol 2012; 77(1): 40-8.
81. Geerlings SE, Stolk RP, Camps MJ, et al. Asymptomatic bacteriuria may be considered a complication in women with diabetes. Diabetes Mellitus Women Asymptomatic Bacteriuria Utrecht Study Group. Diabetes Care 2000; 23(6): 744-9.
82. Makuyana D, Mhlabi D, Chipfupa M, Munyombwe T, Gwanzura L. Asymptomatic bacteriuria among outpatients with diabetes mellitus in an urban black population. Cent Afr J Med 2002; 48(7-8): 78-82.
83. Bonadio M, Boldrini E, Forotti G, et al. Asymptomatic bacteriuria in women with diabetes: influence of metabolic control. Clin Infect Dis 2004; 38(6): e41-5.
84. Boyko EJ, Fihn SD, Scholes D, Abraham L, Monsey B. Risk of urinary tract infection and asymptomatic bacteriuria among diabetic and nondiabetic postmenopausal women. Am J Epidemiol 2005; 161(6): 557-64.
85. Bonadio M, Costarelli S, Morelli G, Tartaglia T. The influence of diabetes mellitus on the spectrum of uropathogens and the antimicrobial resistance in elderly adult patients with urinary tract infection. BMC Infect Dis 2006; 6: 54.
86. Harding GK, Zhanel GG, Nicolle LE, Cheang M. Antimicrobial treatment in diabetic women with asymptomatic bacteriuria. N Engl J Med 2002; 347(20): 1576-83.
87. Czaja CA, Rutledge BN, Cleary PA, Chan K, Stapleton AE, Stamm WE. Urinary tract infections in women with type 1 diabetes mellitus: survey of female participants in the epidemiology of diabetes interventions and complications study cohort. J Urol 2009; 181(3): 1129-34.
88. Sanden AK, Johansen MB, Pedersen L, Lervang HH, Schonheyder HC, Thomsen RW. Change from oral antidiabetic therapy to insulin and risk of urinary tract infections in Type 2 diabetic patients: a population-based prescription study. J Diabetes Complications 2010; 24(6): 375-81.
89. Boyko EJ, Fihn SD, Scholes D, Chen CL, Normand EH, Yarbro P. Diabetes and the risk of acute urinary tract infection among postmenopausal women. Diabetes Care 2002; 25(10): 1778-83.
90. Brown JS, Vittinghoff E, Kanaya AM, Agarwal SK, Hulley S, Foxman B. Urinary tract infections in postmenopausal women: effect of hormone therapy and risk factors. Obstet Gynecol 2001; 98(6): 1045-52.
91. Nicolle L, Zhanel G, Harding G. Microbiological outcomes in women with diabetes and untreated asymptomatic bacteriuria. World J Urol 2006; 24(1): 61-5.
92. Scholes D, Hooton TM, Roberts PL, Gupta K, Stapleton AE, Stamm WE. Risk factors associated with acute pyelonephritis in healthy women. Ann Intern Med 2005; 142(1): 20-7.
93. Kofteridis DP, Papadimitraki E, Mantadakis E, et al. Effect of diabetes mellitus on the clinical and microbiological features of hospitalized elderly patients with acute pyelonephritis. J Am Geriatr Soc 2009; 57(11): 2125-8.
94. Efstathiou SP, Pefanis AV, Tsioulos DI, et al. Acute pyelonephritis in adults: prediction of mortality and failure of treatment. Arch Intern Med 2003; 163(10): 1206-12.
95. Rassias AJ, Marrin CA, Arruda J, Whalen PK, Beach M, Yeager MP. Insulin infusion improves neutrophil function in diabetic cardiac surgery patients. Anesth Analg 1999; 88(5): 1011-6.
96. Ingberg C, Palmer M, Schvarcz E, Åman J. Prevalence of urinary tract symptoms in long-standing type 1 diabetes mellitus. Diabetes Metab 1998; 24: 351-4.
97. Ribera MC, Pascual R, Orozco D, Perez BC, Pedrera V, Gil V. Incidence and risk factors associated with urinary tract infection in diabetic patients with and without asymptomatic bacteriuria. Eur J Clin Microbiol Infect Dis 2006; 25(6): 389-93.
98. Stapleton A. Urinary tract infections in patients with diabetes. Am J Med 2002; 113 (Suppl 1A): 80S-4.
99. Geerlings SE, Meiland R, van Lith EC, Brouwer EC, Gaastra W, Hoepelman AI. Adherence of type 1-fimbriated Escherichia coli to uroepithelial cells: more in diabetic women than in control subjects. Diabetes Care 2002; 25(8): 1405-9.
100. Thomsen RW, Jepsen P, Sorensen HT. Diabetes mellitus and pyogenic liver abscess: risk and prognosis. Clin Infect Dis 2007; 44(9): 1194-201.
101. Hu KK, Boyko EJ, Scholes D, et al. Risk factors for urinary tract infections in postmenopausal women. Arch Intern Med 2004; 164(9): 989-93.
102. Martin GS, Mannino DM, Eaton S, Moss M. The Epidemiology of Sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348(16): 1546-54.
103. Sogaard M, Norgaard M, Dethlefsen C, Schonheyder HC. Temporal Changes in the Incidence and 30-Day Mortality associated with Bacteremia in Hospitalized Patients from 1992 through 2006: A Population-based Cohort Study. Clin Infect Dis 2011; 52(1): 61-9.
104. Bryan CS, Reynolds KL, Metzger WT. Bacteremia in diabetic patients: comparison of incidence and mortality with nondiabetic patients. Diabetes Care 1985; 8(3): 244-9.
105. Carton JA, Maradona JA, Nuno FJ, Fernandez-Alvarez R, Perez-Gonzalez F, Asensi V. Diabetes mellitus and bacteraemia: a comparative study between diabetic and non-diabetic patients. Eur J Med 1992; 1(5): 281-7.
106. Weiderpass E, Gridley G, Nyren O, Pennello G, Landstrom AS, Ekbom A. Cause-specific mortality in a cohort of patients with diabetes mellitus: a population-based study in Sweden. J Clin Epidemiol 2001; 54(8): 802-9.
107. Tsai CL, Lee CC, Ma MH, et al. Impact of diabetes on mortality among patients with community-acquired bacteremia. J Infect 2007; 55(1): 27-33.
108. Stoeckle M, Kaech C, Trampuz A, Zimmerli W. The role of diabetes mellitus in patients with bloodstream infections. Swiss Med Wkly 2008; 138(35-36): 512-9.
109. Community-acquired pneumonia in adults in British hospitals in 1982-1983: a survey of aetiology, mortality, prognostic factors and outcome. The British Thoracic Society and the Public Health Laboratory Service. Q J Med 1987; 62(239): 195-220.
110. Fine MJ, Smith MA, Carson CA, et al. Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA 1996; 275(2): 134-41.
111. Johansson N, Kalin M, Tiveljung-Lindell A, Giske CG, Hedlund J. Etiology of Community-Acquired Pneumonia: Increased Microbiological Yield with New Diagnostic Methods. Clin Infect Dis 2010; 50(2): 202-9.
112. File TM, Marrie TJ. Burden of Community-Acquired Pneumonia in North American Adults. Postgrad Med 2010; 122(2): 130-41.
113. Basi SK, Marrie TJ, Huang JQ, Majumdar SR. Patients admitted to hospital with suspected pneumonia and normal chest radiographs: Epidemiology, microbiology, and outcomes. Am J Med 2004; 117(5): 305-11.
114. Marrie TJ. Bacteraemic pneumococcal pneumonia: a continuously evolving disease. J Infect 1992; 24(3): 247-55.
115. Nielsen SV, Henrichsen J. Incidence of invasive pneumococcal disease and distribution of capsular types of pneumococci in Denmark, 1989-94. Epidemiol Infect 1996; 117(3): 411-6.
116. Gransden WR, Eykyn SJ, Phillips I. Pneumococcal bacteraemia: 325 episodes diagnosed at St Thomas's Hospital. Br Med J (Clin Res Ed) 1985; 290(6467): 505-8.
117. Watanakunakorn C, Greifenstein A, Stroh K, et al. Pneumococcal bacteremia in three community teaching hospitals from 1980 to 1989. Chest 1993; 103(4): 1152-6.
118. Nuorti JP, Butler JC, Farley MM, et al. Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team. N Engl J Med 2000; 342(10): 681-9.
119. Thomsen RW, Hundborg HH, Lervang HH, Johnsen SP, Schonheyder HC, Sorensen HT. Risk of community-acquired pneumococcal bacteremia in patients with diabetes: a populationbased case-control study. Diabetes Care 2004; 27(5): 1143-7.
120. Graff LR, Franklin KK, Witt L, et al. Antimicrobial therapy of gram-negative bacteremia at two university-affiliated medical centers. Am J Med 2002; 112(3): 204-11.
121. Ko WC, Paterson DL, Sagnimeni AJ, et al. Community-acquired Klebsiella pneumoniae bacteremia: global differences in clinical patterns. Emerging Infect Dis 2002; 8(2): 160-6.
122. Wang JH, Liu YC, Lee SSJ, et al. Primary liver abscess due to Klebsiella pneumoniae in Taiwan. Clin Infect Dis 1998; 26(6): 1434-8.
123. Tsai FC, Huang YT, Chang LY, Wang JT. Pyogenic liver abscess as endemic disease, Taiwan. Emerging Infect Dis 2008; 14(10): 1592-600.
124. Thomsen RW, Jepsen P, Sorensen HT. Diabetes mellitus and pyogenic liver abscess: risk and prognosis. Clin Infect Dis 2007; 44(9): 1194-201.
125. Kaplan GG, Gregson DB, Laupland KB. Population-based study of the epidemiology of and the risk factors for pyogenic liver abscess. Clin Gastroenterol Hepatol 2004; 2(11): 1032-8.
126. Guérin JM. Septicémies chez le diabétique. Sem Hop Paris 1992; 68: 176-9.
127. Jackson LA, Benson P, Neuzil KM, Grandjean M, Marino JL. Burden of Community-Onset Escherichia coli Bacteremia in Seniors. J Infect Dis 2005; 191(9): 1523-9.
128. Thomsen RW, Hundborg HH, Lervang HH, Johnsen SP, Schonheyder HC, Sorensen HT. Diabetes mellitus as a risk and prognostic factor for community-acquired bacteremia due to enterobacteria: a 10-year, population-based study among adults. Clin Infect Dis 2005; 40(4): 628-31.
129. Peralta G, Sanchez MB, Roiz MP, Garrido JC, Teira R, Mateos F. Diabetes does not affect outcome in patients with Enterobacteriaceae bacteremia. BMC Infect Dis 2009; 9: 94.
130. Laupland KB, Gregson DB, Church DL, Ross T, Pitout JDD. Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region. Clin Microbiol Infect 2008; 14(11): 1041-7.
131. Ekelund K, Skinhoj P, Madsen J, Konradsen HB. Invasive group A, B, C and G streptococcal infections in Denmark 1999-2002: epidemiological and clinical aspects. Clin Microbiol Infect 2005; 11(7): 569-76.
132. Lamagni TL, Darenberg J, Luca-Harari B, et al. Epidemiology of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol 2008; 46(7): 2359-67.
133. Laupland KB, Ross T, Church DL, Gregson DB. Population-based surveillance of invasive pyogenic streptococcal infection in a large Canadian region. Clin Microbiol Infect 2006; 12(3): 224-30.
134. Skoff TH, Farley MM, Petit S, et al. Increasing burden of invasive group B streptococcal disease in nonpregnant adults, 1990-2007. Clin Infect Dis 2009; 49(1): 85-92.
135. Sendi P, Johansson L, Norrby-Teglund A. Invasive group B streptococcal disease in non-pregnant adults. Infection 2008; 36(2): 100-11.
136. Opal SM, Cross A, Palmer M, Almazan R. Group B streptococcal sepsis in adults and infants. Contrasts and comparisons. Arch Intern Med 1988; 148(3): 641-5.
137. Schwartz B, Schuchat A, Oxtoby MJ, Cochi SL, Hightower A, Broome CV. Invasive group B streptococcal disease in adults. A population-based study in metropolitan Atlanta. JAMA 1991; 266(8): 1112-4.
138. Farley MM, Harvey RC, Stull T, et al. A population-based assessment of invasive disease due to group B Streptococcus in nonpregnant adults. N Engl J Med 1993; 328(25): 1807-11.
139. Munoz P, Llancaqueo A, Rodriguez-Creixems M, Pelaez T, Martin L, Bouza E. Group B streptococcus bacteremia in nonpregnant adults. Arch Intern Med 1997; 157(2): 213-6.
140. Perovic O, Crewe-Brown HH, Khoosal M, Karstaedt AS. Invasive group B streptococcal disease in nonpregnant adults. Eur J Clin Microbiol Infect Dis 1999; 18(5): 362-4.
141. Tyrrell GJ, Senzilet LD, Spika JS, et al. Invasive disease due to group B streptococcal infection in adults: results from a Canadian, population-based, active laboratory surveillance study--1996. Sentinel Health Unit Surveillance System Site Coordinators. J Infect Dis 2000; 182(1): 168-73.
142. Blancas D, Santin M, Olmo M, Alcaide F, Carratala J, Gudiol F. Group B streptococcal disease in nonpregnant adults: incidence, clinical characteristics, and outcome. Eur J Clin Microbiol Infect Dis 2004; 23(3): 168-73.
143. Matsubara K, Yamamoto G. Invasive group B streptococcal infections in a tertiary care hospital between 1998 and 2007 in Japan. Int J Infect Dis 2009; 13(6): 679-84.
144. Factor SH, Levine OS, Schwartz B, et al. Invasive group A streptococcal disease: risk factors for adults. Emerging Infect Dis 2003; 9(8): 970-7.
145. Jackson LA, Hilsdon R, Farley MM, et al. Risk factors for group B streptococcal disease in adults. Ann Intern Med 1995; 123(6): 415-20.
146. Laupland KB, Ross T, Gregson DB. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006. J Infect Dis 2008; 198(3): 336-43.
147. Cox NH. Oedema as a risk factor for multiple episodes of cellulitis/erysipelas of the lower leg: a series with community follow-up. Br J Dermatol 2006; 155(5): 947-50.
148. Cheer K, Shearman C, Jude EB. Managing complications of the diabetic foot. BMJ 2009; 339: b4905.
149. Lipsky B, Tabak Y, Johannes R, Vo L, Hyde L, Weigelt J. Skin and soft tissue infections in hospitalised patients with diabetes: culture isolates and risk factors associated with mortality, length of stay and cost. Diabetologia 2010; 53(5): 914-23.
150. Thomsen RW, Kasatpibal N, Riis A, Norgaard M, Sorensen HT. The impact of pre-existing heart failure on pneumonia prognosis: population-based cohort study. J Gen Intern Med 2008; 23(9): 1407-13.
151. Wong SS, Lin YS, Mathew L, Rajagopal L, Sepkowitz D. Increase in group G streptococcal infections in a community hospital, New York, USA. Emerging Infect Dis 2009; 15(6): 991-3.
152. Lipsky BA, Pecoraro RE, Chen MS, Koepsell TD. Factors affecting staphylococcal colonization among NIDDM outpatients. Diabetes Care 1987; 10(4): 483-6.
153. von Eiff C, Becker K, Machka K, Stammer H, Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med 2001; 344(1): 11-6.
154. Monami M, Mannucci E, Masotti G. Finger sepsis in two poorly controlled diabetic patients with reuse of lancets. Diabetes Care 2002; 25(6): 1103.
155. Venmans LMAJ, Gorter KJ, Hak E, Rutten GEHM. Short-Term Effects of an Educational Program on Health-Seeking Behavior for Infections in Patients With Type 2 Diabetes: A randomized controlled intervention trial in primary care. Diabetes Care 2008; 31(3): 402-7.
156. Thomsen RW, Hundborg HH, Lervang HH, Johnsen SP, Sorensen HT, Schonheyder HC. Diabetes and outcome of communityacquired pneumococcal bacteremia: a 10-year population-based cohort study. Diabetes Care 2004; 27(1): 70-6.
157. Rothman KJ. Epidemiology: an introduction. 1st ed. New York: Oxford University Press 2002.
158. Das UN. Is insulin an antiinflammatory molecule? Nutrition 2001; 17(5): 409-13.
159. Hansen TK, Thiel S, Wouters PJ, Christiansen JS, van den Berghe G. Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab 2003; 88: 1082-8.
160. Brix-Christensen V, Andersen SK, Andersen R, et al. Acute hyperinsulinemia restrains endotoxin-induced systemic inflammatory response. Anesthesiology 2004; 100(4): 861-70.
161. Osuchowski MF, Craciun FL, Schuller E, Sima C, Gyurko R, Remick DG. Untreated type 1 diabetes increases sepsis-induced mortality without inducing a prelethal cytokine response. Shock 2010; 34(4): 369-76.
162. Dandona P, Chaudhuri A, Ghanim H, Mohanty P. Antiinflammatory effects of insulin and the pro-inflammatory effects of glucose. Semin Thorac Cardiovasc Surg 2006; 18(4): 293-301.
163. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. Creactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001; 286(3): 327-34.
164. Jain SK, Kannan K, Lim G, Matthews-Greer J, McVie R, Bocchini JA, Jr. Elevated blood interleukin-6 levels in hyperketonemic type 1 diabetic patients and secretion by acetoacetate-treated cultured U937 monocytes. Diabetes Care 2003; 26(7): 2139-43.
165. Geerlings SE, Brouwer EC, Van Kessel KC, Gaastra W, Stolk RP, Hoepelman AI. Cytokine secretion is impaired in women with diabetes mellitus. Eur J Clin Invest 2000; 30(11): 995-1001.
166. Andreasen AS, Pedersen-Skovsgaard T, Berg RM, et al. Type 2 diabetes mellitus is associated with impaired cytokine response and adhesion molecule expression in human endotoxemia. Intensive Care Med 2010; 36(9): 1548-55.
167. Muller YL, Hanson RL, Bian L, et al. Functional variants in MBL2 are associated with type 2 diabetes and pre-diabetes traits in Pima Indians and the old order Amish. Diabetes 2010; 59(8): 2080-5.
168. Fernandez-Real JM, Straczkowski M, Vendrell J, et al. Protection from inflammatory disease in insulin resistance: the role of mannan-binding lectin. Diabetologia 2006; 49(10): 2402-11.
169. Moss M, Guidot DM, Steinberg KP, et al. Diabetic patients have a decreased incidence of acute respiratory distress syndrome. Crit Care Med 2000; 28(7): 2187-92.
170. Esper AM, Moss M, Martin GS. The effect of diabetes mellitus on organ dysfunction with sepsis: an epidemiological study. Crit Care 2009; 13(1): R18.
171. Castellanos MR, Szerszen A, Saifan C, et al. Fasting hyperglycemia upon hospital admission is associated with higher pneumonia complication rates among the elderly. Int Arch Med 2010; 3: 16.
172. Schuetz P, Jones AE, Howell MD, et al. Diabetes Is Not Associated With Increased Mortality in Emergency Department Patients With Sepsis. Ann Emerg Med 2011; 58(5): 438-44.
173. Delamaire M, Maugendre D, Moreno M, Le Goff MC, Allannic H, Genetet B. Impaired leucocyte functions in diabetic patients. Diabet Med 1997; 14(1): 29-34.
174. Kjersem H, Hilsted J, Madsbad S, Wandall JH, Johansen KS, Borregaard N. Polymorphonuclear leucocyte dysfunction during short term metabolic changes from n. Infection 1988; 16(4): 215-21.
175. Marhoffer W, Stein M, Schleinkofer L, Federlin K. Evidence of ex vivo and in vitro impaired neutrophil oxidative burst and phagocytic capacity in type 1 diabetes mellitus. Diabetes Res Clin Pract 1993; 19(3): 183-8.
176. Rayfield EJ, Ault MJ, Keusch GT, Brothers MJ, Nechemias C, Smith H. Infection and diabetes: the case for glucose control. Am J Med 1982; 72(3): 439-50.
177. Perioperative total parenteral nutrition in surgical patients. The Veterans Affairs Total Parenteral Nutrition Cooperative Study Group. N Engl J Med 1991; 325(8): 525-32.
178. Moore FA, Feliciano DV, Andrassy RJ, et al. Early enteral feeding, compared with parenteral, reduces postoperative septic complications. The results of a meta-analysis. Ann Surg 1992; 216(2): 172-83.
179. Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 1999; 67(2): 352-60.
180. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345(19): 1359-67.
181. Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360(13): 1283-97.
182. Egi M, Finfer S, Bellomo R. Glycemic control in the ICU. Chest 2011; 140(1): 212-20.
183. Johnston CLW. Infection and diabetes mellitus. In: Pickup J, Williams G, Eds. Textbook of diabetes. Oxford: Blackwell Science 1997; pp. 1-14.
184. Campbell IW, Munro JF, McCuish AC, Duncan LJ. Infection and severe diabetic metabolic decompensation. Practitioner 1974; 213(1278): 813-8.
185. Soler NG, Bennett MA, Fitzgerald MG, Malins JM. Intensive care in the management of diabetic ketoacidosis. Lancet 1973; 1(7810): 951-4.
186. Watkins PJ, Soler NG, Fitzgerald MG, Malins JM. Diabetic ketoacidosis during the influenza epidemic. Br Med J 1970; 4(727): 89-91.
187. Azoulay E, Chevret S, Didier J, et al. Infection as a trigger of diabetic ketoacidosis in intensive care-unit patients. Clin Infect Dis 2001; 32(1): 30-5.
188. Gogos CA, Giali S, Paliogianni F, Dimitracopoulos G, Bassaris HP, Vagenakis AG. Interleukin-6 and C-reactive protein as early markers of sepsis in patients with diabetic ketoacidosis or hyperosmosis. Diabetologia 2001; 44(8): 1011-4.